Early diagnosis of Alzheimer's disease: Contribution of structural neuroimaging

NeuroImage

Volumn 18, Issue 2, 2003, Pages 525-541

  Chetelat, Gaël ^a   Baron, Jean Claude ^b  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; AMNESIA; ASSOCIATION CORTEX; BRAIN ATROPHY; BRAIN SIZE; CADAVER; CINGULATE GYRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EARLY DIAGNOSIS; ENTORHINAL CORTEX; FOLLOW UP; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK; TEMPORAL CORTEX; TEMPORAL LOBE; TISSUE SECTION; TISSUE STRUCTURE;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; ENTORHINAL CORTEX; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 0037330921     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-8119(02)00026-5     Document Type: Review

References (133)

1. American Psychiatric Association, 1994. In: DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Am. Psychiatric Assoc. Press, Washington, DC.
2. Bamford K.A., Caine E.D. Does "benign senescent forgetfulness" exist? Clin. Geriatr. Med. 4:1988;897-916.
3. Barker A., Jones R., Jennison C. A prevalence study of age-associated memory impairment. Br. J Psychiatry. 167:1995;642-648.
4. Baron J.C., Chételat G., Desgranges B., Perchey G., Landeau B., de la Sayette V., Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage. 14:2001;298-308.
5. Blackford R.C., La Rue A. Criteria for diagnosing age-associated memory impairment Proposed improvements from the field . Dev. Neuropsychol. 5:1989;295-306.
6. Bobinski M., de Leon M.J., Convit A., de Santi S., Wegiel J., Tarshish C.Y., Saint L.L., Wisniewski H.M. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet. 353:1999;38-40.
7. Bobinski M., de Leon M.J., Wegiel J., Desanti S., Convit A., Saint L.L., Rusinek H., Wisniewski H.M. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience. 95:2000;721-725.
8. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Reisberg B., de Leon M.J., Miller D.C. Neurofibrillary pathology - Correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging. 17:1996;909-919.
9. Boss M.A. Diagnostic approaches to Alzheimer's disease. Biochem. Biophys. Acta. 1502:2000;188-200.
10. Bowen J., Teri L., Kukull W., McCormick W., McCurry S.M., Larson E.B. Progression to dementia in patients with isolated memory loss. Lancet. 5:1997;763-765.
11. Bozoki A., Giordani B., Heidebrink J.L., Berent S., Foster N.L. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch. Neurol. 58:2001;411-416.
12. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 165:1996;3-12.
13. Braak H., Braak E., Bohl J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 33:1993;403-408.
14. Burggren A.C., Bookheimer S.Y. Structural and functional neuroimaging in Alzheimer's disease an update . Curr. Top. Med. Chem. 2:2002;385-393.
15. Caine E.D. Should aging-associated cognitive decline be included in DSM-IV? J. Neuropsychiatry Clin. Neurosci. 5:1993;1-5.
16. Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Ann. Med. 32:2000;6-14.
17. Chan D., Fox N.C., Scahill R.I., Crum W.R., Whitwell J.L., Leschziner G., Rossor A.M., Stevens J.M., Cipolotti L., Rossor M.N. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann. Neurol. 49:2001;433-442.
18. Chen P., Ratcliff G., Belle S.H., Cauley J.A., DeKosky S.T., Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 55:2000;1847-1853.
19. Chetelat G., Desgranges B., de la Sayette V., Vinder F., Eustache F., Baron J.-C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. NeuroReport. 13:2002;1939-1943.
20. Convit A., de Leon M.J., Golomb J., George A.E., Tarshish C.Y., Bobinski M., Tsui W., de Santi S., Wegiel J., Wisniewski H. Hippocampal atrophy in early Alzheimer's disease anatomic specificity and validation . Psychiatry Q. 64:1993;371-387.
21. Convit A., de Leon M.J., Tarshish C., de Santi S., Tsui W., Rusinek H., George A. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol. Aging. 18:1997;131-138.
22. Convit A., de Asis J., De Leon M.J., Tarshish C.Y., De Santi S., Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol. Aging. 21:2000;19-26.
23. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
24. Coria F., Gomez d.C.J., Minguez L., Rodriguez-Artalejo F., Claveria L.E. Prevalence of age-associated memory impairment and dementia in a rural community. J. Neurol. Neurosurg. Psychiatry. 56:1993;973-976.
25. Crook T., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D., Gershon S. Age-associated memory Impairment proposed diagnostic criteria and measures of clinical changes - Report of a National Institute of Mental Health Work Group . Dev. Neuropsychol. 2:1986;261-276.
26. Crook T.H. Diagnosis and treatment of normal and pathologic memory impairment in later life. Semin. Neurol. 9:1989;20-30.
27. Cuenod C.A., Denys A., Michot J.L., Jehenson P., Forette F., Kaplan D., Syrota A., Boller F. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch. Neurol. 50:1993;941-945.
28. Daly E., Zaitchik D., Copeland M., Schmahmann J., Gunther J., Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch. Neurol. 57:2000;675-680.
29. de la Monte S.M. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann. Neurol. 25:1989;450-459.
30. de Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer's disease the atrophic hippocampus . Lancet. 2:1987;672-673.
31. de Leon M.J., Golomb J., George A.E., Convit A., Tarshish C.Y., McRae T., de Santi S., Smith G., Ferris S.H., Noz M. The radiologic prediction of Alzheimer disease the atrophic hippocampal formation . AJNR Am. J Neuroradiol. 14:1993;897-906.
32. De Leon M.J., Convit A., de Santi S., Bobinski M. Structural neuroimaging early diagnosis and staging of Alzheimer's disease . Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski H.M. Alzheimer's Disease and Related Disorders. Vol. 14:1999;105-126 Wiley, New York.
33. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52:1999;1158-1165.
34. de Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging. 22:2001;529-539.
35. Detoledo-Morrell L., Sullivan M.P., Morrell F., Wilson R.S., Bennett D.A., Spencer S. Alzheimer's disease in vivo detection of differential vulnerability of brain regions . Neurobiol. Aging. 18:1997;463-468.
36. Dickerson B.C., Goncharova I., Sullivan M.P., Forchetti C., Wilson R.S., Bennett D.A., Beckett L.A., Detoledo-Morrell L. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol. Aging. 22:2001;747-754.
37. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., Yaffe K., Kramer J.H., Reed B., Norman D., Chui H.C., Weiner M.W. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 71:2001;441-447.
38. Duvernoy H. The Human Hippocampus An Atlas of Applied Anatomy . 1988;Springer-Verlag, New York.
39. Eichenbaum H., Schoenbaum G., Young B., Bunsey M. Functional organization of the hippocampal memory system. Proc. Natl. Acad. Sci. USA. 93:1996;13500-13507.
40. Erkinjuntti T., Lee D.H., Gao F., Steenhuis R., Eliasziw M., Fry R., Merskey H., Hachinski V.C. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch. Neurol. 50:1993;305-310.
41. Fabrigoule C., Lafont S., Letenneur L., Rouch I., Dartigues J.F. WAIS similarities subtests performances as predictors of dementia in elderly community residents. Brain Cogn. 30:1996;323-326.
42. Flicker C., Ferris S.H., Reisberg B. Mild cognitive impairment in the elderly predictors of dementia . Neurology. 41:1991;1006-1009.
43. Fox N.C., Rossor M.N. Diagnosis of early Alzheimer's disease. Rev. Neurol. 155:(Suppl. 4):1999;S33-S37.
44. Fox N.C., Freeborough P.A., Rossor M.N. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet. 348:1996;94-97.
45. Fox N.C., Warrington E.K., Freeborough P.A., Hartikainen P., Kennedy A.M., Stevens J.M., Rossor M.N. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 119:1996;2001-2007.
46. Fox N.C., Warrington E.K., Stevens J.M., Rossor M.N. Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation. Ann. N.Y. Acad. Sci. 777:1996;226-232.
47. Fox N.C., Warrington E.K., Rossor M.N. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet. 353:1999;2125.
48. Fox N.C., Crum W.R., Scahill R.I., Stevens J.M., Janssen J.C., Rossor M.N. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 358:2001;201-205.
49. Frisoni G.B., Beltramello A., Weiss C., Geroldi C., Bianchetti A., Trabucchi M. Linear measures of atrophy in mild Alzheimer disease. AJNR. Am. J Neuroradiol. 17:1996;913-923.
50. Frisoni G.B., Laakso M.P., Beltramello A., Geroldi C., Bianchetti A., Soininen H., Trabucchi M. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology. 52:1999;91-100.
51. Frisoni G.B. Structural imaging in the clinical diagnosis of Alzheimer's disease problems and tools . J. Neurol. Neurosurg. Psychiatry. 70:2001;711-718.
52. Gomez-Isla T., Price J.L., McKeel D.W. Jr., Morris J.C., Growdon J.H., Hyman B.T. Profond loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. of Neurosci. 16:1996;4491-4500.
53. Goshe K.M., Mortimer J.A., Smith C.D., Markesbery W.R., Snowdoon D.A. A technique for measuring hippocampal volumes from MR imaging studies. AJNR Am. J. Neuroradiol. 22:2001;1686-1689.
54. Hampel H., Teipel S.J., Bayer W., Alexander G.E., Schwarz R., Schapiro M.B., Rapoport S.I., Moller H.J. Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease. J. Neurol. Sci. 194:2002;15-19.
55. Hanninen T., Koivisto K., Reinikainen K.J., Helkala E.L., Soininen H., Mykkanen L., Laakso M., Riekkinen P.J. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing. 25:1996;201-205.
56. Hanninen T., Soininen H. Age-associated memory impairment. Normal aging or warning of dementia? Drugs Aging. 11:1997;480-489.
57. Hensel A., Wolf H., Kruggel F., Riedel-Heller S.G., Nikolaus C., Arendt T., Gertz H.J. Morphometry of the corpus callosum in patients with questionable and mild dementia. J. Neurol. Neurosurg. Psychiatry. 73:2002;59-61.
58. Ikeda M., Tanabe H., Nakagawa Y., Kazui H., Oi H., Yamazaki H., Harada K., Nishimura T. MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology. 36:1994;7-10.
59. Insausti R., Juottonen K., Soininen H., Insausti A.M., Partanen K., Vainio P., Laakso M.P., Pitkanen A. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am. J. Neuroradiol. 19:1998;659-671.
60. Ishii K. Value of interuncal distance measure in diagnosis of Alzheimer disease questioned. AJNR. Am. J. Neuroradiol. 15:1994;1286-1290.
61. Jack C.R., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Tangalos E.G., Kokmen E. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 55:2000;484-489.
62. Jack C.R.J., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
63. Jack C.R.J., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., Smith G.E., Ivnik R.J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 49:1997;786-794.
64. Jobst K.A., Smith A.D., Szatmari M., Molyneux A., Esiri M.E., King E., Smith A., Jaskowski A., McDonald B., Wald N. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet. 340:1992;1179-1183.
65. Juottonen K., Laakso M.P., Insausti R., Lehtovirta M., Pitkanen A., Partanen K., Soininen H. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol. Aging. 19:1998;15-22.
66. Juottonen K., Laakso M.P., Partanen K., Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR. Am. J. Neuroradiol. 20:1999;139-144.
67. Kaye J.A., Swihart T., Howieson D., Dame A., Moore M.M., Karnos T., Camicioli R., Ball M., Oken B., Sexton G. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 48:1997;1297-1304.
68. Killiany R.J., Moss M.B., Albert M.S., Sandor T., Tieman J., Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch. Neurol. 50:1993;949-954.
69. Killiany R.J., Gomez-Isla T., Moss M., Kikinis R., Sandor T., Jolesz F., Tanzi R., Jones K., Hyman B.T., Albert M.S. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann. Neurol. 47:2000;430-439.
70. Killiany R.J., Hyman B.T., Gomez-Isla T., Moss M.B., Kikinis R., Jolesz F., Tanzi R., Jones K., Albert M.S. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 58:2002;1188-1196.
71. Knopman D.S., DeKosky S.T., Cummings J.L., et al. Practice parameter diagnosis of dementia (an evidence-based review) . Neurology. 56:2001;1143-1153.
72. Koivisto K., Reinikainen K.J., Hanninen T., Vanhanen M., Helkala E.L., Mykkanen L., Laakso M., Pyorala K., Riekkinen P.J.S. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology. 45:1995;741-747.
73. Kordower J.H., Chu Y., Stebbins G.T., DeKosky S.T., Cochran E.J., Bennett D., Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49:2001;202-213.
74. Kral V.A. Senescent forgetfulness benign and malignant . J. Can. Med. Assoc. 86:1962;257-260.
75. Krasuski J.S., Alexander G.E., Horwitz B., Daly E.M., Murphy D.G., Rapoport S.I., Schapiro M.B. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry. 43:1998;60-68.
76. Laakso M.P., Hallikainen M., Hanninen T., Partanen K., Soininen H. Diagnosis of Alzheimer's disease MRI of the hippocampus vs delayed recall . Neuropsychologia. 38:2000;579-584.
77. Laakso M.P., Partanen K., Lehtovirta M., Hallikainen M., Hanninen T., Vainio P., Riekkinen P.S., Soininen H. MRI of amygdala fails to diagnose early Alzheimer's disease. NeuroReport. 6:1995;2414-2418.
78. Laakso M.P., Soininen H., Partanen K., Helkala E.L., Hartikainen P., Vainio P., Hallikainen M., Hanninen T., Riekkinen P.J.S. Volumes of hippocampus amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease correlation with memory functions . J. Neural Transm. Park. Dis. Dement. Sect. 9:1995;73-86.
79. Laakso M.P., Soininen H., Partanen K., Lehtovirta M., Hallikainen M., Hanninen T., Helkala E.L., Vainio P., Riekkinen P.J.S. MRI of the hippocampus in Alzheimer's disease sensitivity, specificity, and analysis of the incorrectly classified subjects . Neurobiol. Aging. 19:1998;23-31.
80. Lehericy S., Baulac M., Chiras J., Pierot L., Martin N., Pillon B., Deweer B., Dubois B., Marsault C. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am. J Neuroradiol. 15:1994;929-937.
81. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int. Psychogeriatr. 6:1994;63-68.
82. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann. Nucl. Med. 15:2001;85-92.
83. Matsuda H., Kitayama N., Ohnishi T., Asada T., Nakano S., Sakamoto S., Imabayashi E., Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nucl. Med. 43:2002;304-311.
84. Maunoury C., Michot J.L., Caillet H., Parlato V., Leroy-Willig A., Jehenson P., Syrota A., Boller F. Specificity of temporal amygdala atrophy in Alzheimer's disease quantitative assessment with magnetic resonance imaging . Dementia. 7:1996;10-14.
85. McKelvey R., Bergman H., Stern J., Rush C., Zahirney G., Chertkow H. Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can. J Neurol Sci. 26:1999;23-28.
86. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
87. Mega M.S., Thompson P.M., Toga A.W., Cummings J.L. Brain mapping in dementia. Mazziotta J.C., Frackowiak R.S.J., Toga A. Brain Mapping The Disorders . 2000;217-239 Academic Press, San Diego.
88. Meguro K., Le Mestric C., Landeau B., Desgranges B., Eustache F., Baron J.C. Relationships between posterior association cortex hypometabolism and hippocampal atrophy in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 71:2001;315-321.
89. Mizuno K., Wakai M., Takeda A., Sobue G. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease an MRI volumetric and memory assessment study . J. Neurol. Sci. 173:2000;18-24.
90. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology. 55:2000;134-136.
91. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 58:2001;397-405.
92. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science. 278:1997;412-419.
93. Nielsen H., Lolk A., Kragh-Sorensen P. Age-associated memory impairment - Pathological memory decline or normal aging? Scand. J Psychol. 39:1998;33-37.
94. O'Brien J.T., Levy R. Age associated memory impairment. Br. Med. J. 304:1992;5-6.
95. Pantel J., Schroder J., Schad L.R., Friedlinger M., Knopp M.V., Schmitt R., Geissler M., Bluml S., Essig M., Sauer H. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol. Med. 27:1997;221-229.
96. Pantel J., O'Leary D.S., Cretsinger K., Bockholt H.J., Keefe H., Magnotta V.A., Andreasen N.C. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus. 10:2001;752-758.
97. Parnetti L., Lowenthal D.T., Presciutti O., Pelliccioli G.P., Palumbo R., Gobbi G., Chiarini P., Palumbo B., Tarducci R., Senin U. IH-MRS, MRI-based hippocampal volumetry, and 99m Tc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J. Am. Geriatr. Soc. 44:1996;133-138.
98. Petersen R.C., Jack C.R.J., Xu Y.C., Waring S.C., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Boeve B.F., Kokmen E. Memory and MRI-based hippocampal volumes in aging and AD. Neurology. 54:2000;581-587.
99. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., Kokmen E., Waring S.C., Kurland L.T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. J. Am. Med. Assoc. 273:1995;1274-1278.
100. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment clinical characterization and outcome . Arch. Neurol. 56:1999;303-308.
101. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58:2001;1985-1992.
102. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology . Neurology. 56:2001;1133-1142.
103. Price J.L. Diagnostic criteria for Alzheimer's disease. Neurobiol. Aging. 18:(Suppl. 4):1997;S67-S71.
104. Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., de Leon M.J., de Santi S., Convit A., Osborne D., Weaver A., Thibodeau S.N. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann. Neurol. 44:1998;288-291.
105. Ritchie K., Artero S., Touchon J. Classification criteria for mild cognitive impairment a population-based validation study . Neurology. 56:2001;37-42.
106. Ritchie K., Touchon J. Mild cognitive impairment conceptual basis and current nosological status . Lancet. 355:2000;225-228.
107. Rombouts S.A., Barkhof F., Witter M.P., Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci. Lett. 19:2000;231-233.
108. Scahill R.I., Schott J.M., Stevens J.M., Rossor M.N., Fox N.C. Mapping the evolution of regional atrophy in Alzheimer's disease unbiased analysis of fluid-registered serial MRI . Proc. Natl. Acad. Sci. USA. 99:2002;4703-4707.
109. Scheltens P. Early diagnosis of dementia neuroimaging . J. Neurol. 246:1999;16-20.
110. Scheltens P., Fox N., Barkhof F., De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia beyond exclusion . Lancet Neurol. 1:2002;13-21.
111. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., Kostner G.M. Apolipoprotein E e4 allele in the normal elderly neuropsychologic and brain MRI correlates . Clin. Genet. 50:1996;293-299.
112. Schroder J., Kratz B., Pantel J., Minnemann E., Lehr U., Sauer H. Prevalence of mild cognitive impairment in an elderly community sample. J. Neural. Transm. Suppl. 54:1998;51-59.
113. Seab J.P., Jagust W.J., Wong S.T., Roos M.S., Reed B.R., Budinger T.F. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn. Reson. Med. 8:1988;200-208.
114. Sliwinski M., Lipton R.B., Buschke H., Stewart W. The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J. Gerontol. B. Psychol. Sci. Soc. Sci. 51:1996;217-225.
115. Small G.W., Rabins P.V., Barry P.P., Buckholtz N.S., DeKosky S.T., et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. J. Am. Med. Assoc. 278:1997;1363-1371.
116. Smith A.D., Jobst K.A. Use of structural imaging to study the progression of Alzheimer's disease. Br. Med. Bull. 52:1996;575-586.
117. Smith G., Ivnik R.J., Petersen R.C., Malec J.F., Kokmen E., Tangalos E. Age-associated memory impairment diagnoses problems of reliability and concerns for terminology . Psychol. Aging. 6:1991;551-558.
118. Smith G.E., Petersen R.C., Parisi J.E., Ivnik R.J., Kokmen E., Tangalos E., Waring S. Definition, course, and outcome of Mild Cognitive Impairment. Aging Neuropsychol. Cogn. 3:1996;141-147.
119. Soininen H.S., Partanen K., Pitkanen A., Vainio P., Hanninen T., Hallikainen M., Koivisto K., Riekkinen P.J.S. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment correlation to visual and verbal memory . Neurology. 44:1994;1660-1668.
120. Squire L.R., Zola-Morgan S. The medial temporal lobe memory system. Science. 253:1991;1380-1386.
121. Swann A., O'Brien J., Ames D., Schweitzer I., Desmond P., Tress B. Does hippocampal atrophy on MRI predict cognitive decline? A prospective follow-up study. Int. J Geriatr. Psychiatry. 12:1997;1182-1188.
122. Tohgi H., Takahashi S., Kato E., Homma A., Niina R., Sasaki K., Yonezawa H., Sasaki M. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci. Lett. 236:1997;21-24.
123. van Duijn C.M., Hofman A. Risk factors for Alzheimer's disease the EURODEM collaborative re-analysis of case-control studies . Neuroepidemiology. 11:(Suppl. 1):1992;106-113.
124. Vermersch P., David J.P., Frigard B., Fallet-Bianco C., Wattez A., Petit H., Delacourte A. Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 19:1995;1035-1047.
125. Victoroff J., Mack W.J., Grafton S.T., Schreiber S.S., Chui H.C. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology. 44:1994;2267-2276.
126. Visser P.J., Scheltens P., Verhey F.R., Schmand B., Launer L.J., Jolles J., Jonker C. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J. Neurol. 246:1999;477-485.
127. Visser P.J., Verhey F.R., Hofman P.A.M., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry. 72:2002;491-497.
128. Wahlund L.O., Julin P., Lindqvist J., Scheltens P. Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects correlation with volumetry . Psychiatry Res. 90:1999;193-199.
129. Whalley H.C., Kestelman J.N., Rimmington J.E., Kelso A., Abukmeil S.S., Best J.J., Johnstone E.C., Lawrie S.M. Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project. Psychiatry Res. 91:1999;31-44.
130. Wolf H., Grunwald M., Ecke G.M., Zedlick D., Bettin S., Dannenberg C., Dietrich J., Eschrich K., Arendt T., Gertz H.J. The prognosis of mild cognitive impairment in the elderly. J. Neurol. Transm. Suppl. 54:1998;31-50.
131. Wolf H., Grunwald M., Kruggel F., Riedel-Heller S.G., Angerhofer S., Hojjatoleslami A., Hensel A., Arendt T., Gertz H. Hippocampal volume discriminates between normal cognition questionable and mild dementia in the elderly . Neurobiol. Aging. 22:2001;177-186.
132. Xu Y., Jack C.R.J., O'Brien P.C., Kokmen E., Smith G.E., Ivnik R.J., Boeve B.F., Tangalos R.G., Petersen R.C. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 54:2000;1760-1767.
133. Yamada N., Tanabe H., Kazui H., Ikeda M., Hashimoto M., Nakagawa Y., Wada Y., Okuda J.I. Longitudinal neuropsychological and quantitative MRI assessments in early alzheimer's disease. Alzheimer's Res. 2:1996;29-36.